Mednow Inc.
MDNWF
OTC PK
| 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | 04/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 339.17% | 1,056.89% | 2,288.07% | 3,960.56% | 3,058.10% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 339.17% | 1,056.89% | 2,288.07% | 3,960.56% | 3,058.10% |
| Cost of Revenue | 396.16% | 1,325.53% | 5,007.92% | -- | -- |
| Gross Profit | 135.14% | 416.46% | 475.59% | 567.74% | 589.58% |
| SG&A Expenses | -11.61% | 14.41% | 62.94% | 143.91% | 275.24% |
| Depreciation & Amortization | 151.32% | 389.93% | 625.24% | 762.55% | 929.81% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 92.54% | 154.25% | 219.91% | 305.07% | 409.87% |
| Operating Income | 17.29% | -6.29% | -56.51% | -138.37% | -271.23% |
| Income Before Tax | -25.56% | -53.94% | -119.13% | -230.26% | -272.01% |
| Income Tax Expenses | -77.85% | -- | -- | -- | -- |
| Earnings from Continuing Operations | -25.21% | -51.55% | -115.75% | -224.62% | -269.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 186.72% | 385.31% | 668.97% | -- | -- |
| Net Income | -24.97% | -51.22% | -115.45% | -224.61% | -268.99% |
| EBIT | 17.29% | -6.29% | -56.51% | -138.37% | -271.23% |
| EBITDA | 17.35% | -2.11% | -49.56% | -128.25% | -287.16% |
| EPS Basic | -25.08% | -48.83% | -105.01% | -196.80% | -210.83% |
| Normalized Basic EPS | 15.62% | -6.03% | -51.18% | -121.15% | -213.63% |
| EPS Diluted | -25.08% | -48.83% | -105.01% | -196.80% | -210.83% |
| Normalized Diluted EPS | 15.62% | -6.03% | -51.18% | -121.15% | -213.63% |
| Average Basic Shares Outstanding | -0.11% | 1.97% | 9.00% | 17.07% | 28.03% |
| Average Diluted Shares Outstanding | -0.11% | 1.97% | 9.00% | 17.07% | 28.03% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |